Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Eurofins Scientific SE
  6. News
  7. Summary
    ERF   FR0014000MR3

EUROFINS SCIENTIFIC SE

(ERF)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Eurofins Scientific : Shares in France's Eurofins rally as it targets more coronavirus products

08/06/2020 | 01:45am EST

French laboratories and diagnostics company Eurofins said it hoped to launch more products aimed at detecting the presence of the coronavirus, as it posted an increase in first-half profits, sending its shares to record highs.

Net profits rose 60.9% from a year earlier to 95 million euros (85.92 million pounds).

Revenues increased 7.2% to 2.323 billion euros and Eurofins said it was confident of meeting its 2020 financial targets, which include reaching 5 billion euros of revenues.

Eurofins has launched an array of products to detect the presence of SARS-CoV-2 virus responsible for the COVID-19 disease, buoying its overall performance.

Eurofins shares were up by around 10% in early session trading, at all-time highs. The stock has risen by roughly 30% since the start of 2020, giving Eurofins a market capitalisation of around 12 billion euros.

"A strong performance across the board," wrote brokerage Jefferies, keeping a 'buy' rating on Eurofins' shares.

(Reporting by Sudip Kar-Gupta; Editing by Shri Navaratnam and Edmund Blair)

By Sudip Kar-Gupta


ę Reuters 2020
All news about EUROFINS SCIENTIFIC SE
01/17EUROFINS SCIENTIFIC : Managers' transactions - Director/PDMR Shareholding
PU
01/14Keysight Technologies' Test Tools Picked for 5G Device Validation Services in Taiwan
MT
01/11Eurofins CDMO Expands Spray Drying Capabilities
CI
01/11EUROFINS SCIENTIFIC : Managers' transactions - Director/PDMR Shareholding
PU
01/10EUROFINS SCIENTIFIC : Shares in Issue
PU
01/10European shares slide as rising yields hurt tech stocks
RE
01/07EUROFINS SCIENTIFIC : Managers' transactions - Director/PDMR Shareholding
PU
2021Predilife Taps Eurofins to Conduct Genetic Testing of Saliva Samples
MT
2021EUROFINS SCIENTIFIC : Managers' transactions - Director/PDMR Shareholding
PU
2021EUROFINS SCIENTIFIC : Managers' transactions - Director/PDMR Shareholding
PU
More news
Analyst Recommendations on EUROFINS SCIENTIFIC SE
More recommendations
Financials
Sales 2021 6 522 M 7 402 M 7 402 M
Net income 2021 789 M 895 M 895 M
Net Debt 2021 2 152 M 2 442 M 2 442 M
P/E ratio 2021 22,9x
Yield 2021 1,01%
Capitalization 17 803 M 20 205 M 20 205 M
EV / Sales 2021 3,06x
EV / Sales 2022 3,16x
Nbr of Employees 55 000
Free-Float -
Chart EUROFINS SCIENTIFIC SE
Duration : Period :
Eurofins Scientific SE Technical Analysis Chart | ERF | FR0014000MR3 | MarketScreener
Technical analysis trends EUROFINS SCIENTIFIC SE
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Last Close Price 90,84 €
Average target price 112,50 €
Spread / Average Target 23,8%
EPS Revisions
Managers and Directors
Gilles G. Martin Chairman & Chief Executive Officer
Laurent Lebras Director-Group Finance & Administration
Christian Wurst Chief Operating Officer-Food & Environment Testing
Stuart Anderson Independent Non-Executive Director
FÚrÚchtÚ Pouchantchi Independent Non-Executive Director